QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Résumé Extracto Full Text PDF Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Articles Ahead of Print [Order Reprint] Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Naunton, M. Articles by Jones, G. Search for Related Content PubMed PubMed Citation Articles by Naunton, M. Articles by Jones, G.

WOMEN'S HEALTH

Pharmacist-Provided Quantitative Heel Ultrasound Screening for Rural Women at Risk of Osteoporosis

Research Student, Faculty of Health Science, Tasmanian School of Pharmacy, University of Tasmania, Tasmania, Australia

Gregory M Peterson, PhD MBA

Professor of Pharmacy, Faculty of Health Science, Tasmanian School of Pharmacy, University of Tasmania

Graeme Jones, MD

Professor, Faculty of Health Science, Menzies Research Institute, University of Tasmania

Reprints: Dr. Peterson, Tasmanian School of Pharmacy, University of Tasmania, Private Bag 26, Hobart, TAS 7001, Australia, fax 61-3-62267627, G.Peterson{at}utas.edu.au

BACKGROUND: Osteoporosis is underdiagnosed, and rural communities often have limited technical resources for the assessment of osteoporosis.

OBJECTIVE: To evaluate the impact of a pharmacist, trained in the use of a portable heel ultrasound device, in screening elderly rural women for risk of osteoporosis and determine whether those found to be at risk seek further help and treatment from their general practitioner (GP) following screening.

METHODS: Following promotion of the service, 345 women were recruited from 6 rural community pharmacies in Tasmania, Australia, and underwent quantitative heel ultrasound screening. Women were comprehensively educated on risk factors for osteoporosis and completed a calcium intake questionnaire. Results were forwarded to each woman's GP, and the participants were followed up 3 months later to assess outcomes from the screening procedure.

RESULTS: Approximately 20% of women were shown to be at high risk for osteoporosis; 201 (58%) of these were referred to their GP for further assessment. Sixty-eight percent of women who were screened discussed their results with their GP, and 11% underwent further investigation. Over one-third of women screened began medication (30% calcium, 6% bisphosphonate, 6% vitamin D) for osteoporosis.

CONCLUSIONS: Pharmacist-provided screening for osteoporosis in rural areas is a potentially useful method to identify women at risk for fracture and a convenient time point for discussion of preventive therapy.

Key Words: community pharmacy, osteoporosis screening

Published Online, November 22, 2005. www.theannals.com, DOI 10.1345/aph.1G208

This article has been cited by other articles:

				J. F. Farley and S. J. Blalock Trends and determinants of prescription medication use for treatment of osteoporosis Am. J. Health Syst. Pharm., July 1, 2009; 66(13): 1191 - 1201. [Abstract] [Full Text] [PDF]

				J. Stroup, M. P. Kane, and A. M. Abu-Baker Teriparatide in the treatment of osteoporosis Am. J. Health Syst. Pharm., March 15, 2008; 65(6): 532 - 539. [Abstract] [Full Text] [PDF]

				D. T Gold, I. M Alexander, and M. P Ettinger How Can Osteoporosis Patients Benefit More from Their Therapy? Adherence Issues with Bisphosphonate Therapy Ann. Pharmacother., June 1, 2006; 40(6): 1143 - 1150. [Abstract] [Full Text] [PDF]